About Scipher Medicine
Scipher Medicine is a company based in Waltham (United States) founded in 2014 by Joseph Loscalzo, Albert-Laszlo Barabasi, and Marcell Veidner.. Scipher Medicine has raised $232.56 million across 9 funding rounds from investors including Khosla Ventures, TD Securities and Neuberger Berman. The company has 106 employees as of December 31, 2023. Scipher Medicine has completed 2 acquisitions, including CrossBridge and Yet2. Scipher Medicine offers products and services including Spectra AI Platform, Diagnostics, and Data Lake. Scipher Medicine operates in a competitive market with competitors including Guardant Health, GRAIL, Thrive Earlier Detection, Delfi Diagnostics and BillionToOne, among others.
- Headquarter Waltham, United States
- Employees 106 as on 31 Dec, 2023
- Founders Joseph Loscalzo, Albert-Laszlo Barabasi, Marcell Veidner
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Scipher Medicine
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$232.56 M (USD)
in 9 rounds
-
Latest Funding Round
$5.85 M (USD), Series D
May 02, 2024
-
Investors
Khosla Ventures
& 13 more
-
Employee Count
106
as on Dec 31, 2023
-
Investments & Acquisitions
CrossBridge
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Scipher Medicine
Scipher Medicine offers a comprehensive portfolio of products and services, including Spectra AI Platform, Diagnostics, and Data Lake. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for analyzing patient data to optimize therapy selection.
Tools for biomarker-based therapy decisions in autoimmune diseases.
System for storing and analyzing clinical data for research insights.
Unlock access to complete
Unlock access to complete
Funding Insights of Scipher Medicine
Scipher Medicine has successfully raised a total of $232.56M across 9 strategic funding rounds. The most recent funding activity was a Series D round of $5.85 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series D — $5.8M
-
First Round
First Round
(01 Dec 2015)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Series D - Scipher Medicine | Valuation |
investors |
|
| Feb, 2022 | Amount | Series D - Scipher Medicine | Valuation | Cowen | |
| Mar, 2021 | Amount | Series C - Scipher Medicine | Valuation | aMoon , Northpond Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Scipher Medicine
Scipher Medicine has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include Khosla Ventures, TD Securities and Neuberger Berman. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Secondary market fund focused on LP and direct secondary transactions
|
Founded Year | Domain | Location | |
|
Venture capital funding is provided for technology and healthcare companies.
|
Founded Year | Domain | Location | |
|
Venture capital investments in healthcare are focused on by aMoon.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Scipher Medicine
Scipher Medicine has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CrossBridge and Yet2. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Management consulting, technology scouting, and licensing services are provided.
|
1999 | ||||
|
Chronic care planning and management software is provided.
|
1997 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Scipher Medicine
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Scipher Medicine Comparisons
Competitors of Scipher Medicine
Scipher Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Thrive Earlier Detection, Delfi Diagnostics and BillionToOne, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Blood-based liquid biopsy tests for multiple cancer detection are provided.
|
|
| domain | founded_year | HQ Location |
Provider of DNA sequencing for cancer detection
|
|
| domain | founded_year | HQ Location |
Provider of cell-free cancer liquid biopsy test
|
|
| domain | founded_year | HQ Location |
Liquid biopsy for post-cancer surgery tumor monitoring is provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Scipher Medicine
Frequently Asked Questions about Scipher Medicine
When was Scipher Medicine founded?
Scipher Medicine was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Scipher Medicine located?
Scipher Medicine is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Who is the current CEO of Scipher Medicine?
Alif Saleh is the current CEO of Scipher Medicine.
Is Scipher Medicine a funded company?
Scipher Medicine is a funded company, having raised a total of $232.56M across 9 funding rounds to date. The company's 1st funding round was a Series C of $82M, raised on Dec 01, 2015.
How many employees does Scipher Medicine have?
As of Dec 31, 2023, the latest employee count at Scipher Medicine is 106.
What does Scipher Medicine do?
Scipher Medicine was founded in 2014 in Waltham, United States, within the biotechnology sector. Precision medicine services are offered through a platform that analyzes blood test reports to determine suitable drugs for patients. The PrismRA test is provided to predict responses to anti-TNF therapy prior to prescription. Focus is placed on autoimmune, neurological, and cardiovascular diseases, with operations centered on liquid biopsy technologies.
Who are the top competitors of Scipher Medicine?
Scipher Medicine's top competitors include Guardant Health, GRAIL and BillionToOne.
What products or services does Scipher Medicine offer?
Scipher Medicine offers Spectra AI Platform, Diagnostics, and Data Lake.
How many acquisitions has Scipher Medicine made?
Scipher Medicine has made 2 acquisitions, including CrossBridge, and Yet2.
Who are Scipher Medicine's investors?
Scipher Medicine has 14 investors. Key investors include Khosla Ventures, TD Securities, Neuberger Berman, Monashee Investment Management, and Hitachi Ventures.